Evome Medical Technologies Inc.
LNDZF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -5% | -12.7% | -23.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 35.6% | 31.5% | 32.5% | 35.2% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 11.6% | -13% | -21.6% | -84.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11.5% | -21.7% | -35.5% | -100.6% |
| EPS Diluted | 0 | 0 | 0 | -0.209 |
| % Growth | – | – | 100% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |